Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dee Glaser

Dermatology Saint Louis, MO Medical Doctor

NPI 1962429936 CMS profile 270010

2315 Dougherty Ferry Rd Ste 200, Saint Louis, MO 63122

Open in the dashboard

General payments

$131,037

197 records reported · program years 2019–2025

Research payments

$62,855

Paid to them · 83 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$82,368 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Dee Glaser of Saint Louis, MO is reported in the CMS Open Payments database as having received $131,037 across 197 general payments and $62,855 in research payments paid to them. Separately, studies naming them as principal investigator received $82,368 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,137 18
2025 Research $8,000 1
2024 General $18,968 43
2024 Research $23,739 20
2023 General $17,454 27
2023 Research $26,707 34
2022 General $26,443 27
2022 Research $4,408 28
2021 General $3,390 9
2020 General $9,872 15
2019 General $53,773 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dee Glaser
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Dee Glaser were reported at $1,137. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Dee Glaser Dermatology median Middle half National median
2019 $53,773 $454 $129–$1,240 $163
2020 $9,872 $235 $81–$756 $114
2021 $3,390 $377 $108–$1,108 $132
2022 $26,443 $514 $143–$1,391 $149
2023 $17,454 $607 $159–$1,674 $160
2024 $18,968 $751 $204–$1,903 $164
2025 $1,137 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $52,592 59 payments
  2. Dermira, Inc. $35,897 29 payments
  3. Galderma Laboratories, L.P. $12,068 16 payments
  4. Ortho Dermatologics, a division of Bausch Health US, LLC $9,147 31 payments
  5. Allergan Inc. $8,174 18 payments
  6. Endo Pharmaceuticals Inc. $7,973 8 payments
  7. Incyte Corporation $2,851 3 payments
  8. Solta Medical, a division of Bausch Health US, LLC $415 4 payments
  9. Pfizer Inc. $277 3 payments
  10. Dermavant Sciences, Inc. $249 2 payments
  11. Other $1,394 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $81,267 16 payments
  2. Honoraria $21,375 7 payments
  3. Food and Beverage $8,948 140 payments
  4. Travel and Lodging $8,667 23 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,000 3 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,738 2 payments
  7. Education $42 6 payments
Products named General payments · program years 2019–2025
  1. QBREXZA $35,119 21 payments
  2. BOTOX $20,951 34 payments
  3. ALTRENO $8,319 19 payments
  4. BOTOX COSMETIC $2,802 5 payments
  5. ARAZLO $752 11 payments
  6. DUOBRII $672 8 payments
  7. SILIQ $641 7 payments
  8. JUBLIA $607 7 payments
  9. Cabtreo $342 5 payments
  10. CIBINQO $277 3 payments
  11. Other $2,750 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $62,855 83 payments

Records

280 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record